| Previous close | 0.0100 |
| Open | 0.0200 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 42.50 |
| Expiry date | 2023-12-15 |
| Day's range | 0.0100 - 0.0200 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksOlema Pharmaceuticals (OLMA) Skyrockets 471% YTD: Here's Why
Olema's (OLMA) shares surge on the successful development of its lead candidate in metastatic breast cancer indication.
ZacksGSK Key Drugs & Vaccines Help Stock Outperform Industry YTD
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates are expected drive the stock in the future quarters.
Simply Wall St.Pfizer Inc. (NYSE:PFE) is a favorite amongst institutional investors who own 71%
Key Insights Institutions' substantial holdings in Pfizer implies that they have significant influence over the...
© 2023 Yahoo. All rights reserved.